Matches in SemOpenAlex for { <https://semopenalex.org/work/W2027423344> ?p ?o ?g. }
- W2027423344 endingPage "108" @default.
- W2027423344 startingPage "99" @default.
- W2027423344 abstract "Objective Abnormalities of glucose metabolism are common findings of acromegaly. However, robust evidence on whether therapy with somatostatin analogs (SSAs) or pegvisomant (PEG) differently affects glucose metabolism is lacking. The purpose of this study was to evaluate the effects of therapy with SSAs, PEG, or their combination on glucose metabolism in a large series of acromegalic patients. Design This was a historical–prospective study. Among 50 consecutive acromegalic patients under SSA therapy, acromegaly in 19 patients was controlled. PEG used in combination with SSA therapy allowed the control of acromegaly in the remaining 31 patients and was then continued as monotherapy in 18 patients. Methods The following parameters were evaluated at the diagnosis of acromegaly and during different treatments: fasting plasma glucose (FPG) and insulin concentrations, insulin sensitivity (QUICK-I), homeostasis model assessment of insulin resistance (HOMA2-IR), and plasma glucose and insulin concentrations during the oral glucose tolerance test (OGTT). Comparison was made using analysis for paired data. Results Insulin resistance improved when acromegaly was controlled with therapy with SSAs, PEG, or SSA+PEG. However, FPG concentrations were higher during SSA therapy (alone or combined with PEG) than at the diagnosis of acromegaly, even when corrected for disease activity, whereas they were reduced during PEG therapy. Mean glucose concentrations during the OGTT were higher in patients receiving SSA therapy than in those receiving PEG therapy. In addition, the prevalence of diabetes or impaired glucose tolerance was higher during SSA therapy than at diagnosis or during PEG therapy and was not influenced by disease control. Conclusions Medical therapies for acromegaly reduce insulin resistance and increase insulin sensitivity; on the contrary, glucose indexes may be differently affected by SSA or PEG therapy." @default.
- W2027423344 created "2016-06-24" @default.
- W2027423344 creator A5000187560 @default.
- W2027423344 creator A5014452585 @default.
- W2027423344 creator A5016909731 @default.
- W2027423344 creator A5030686004 @default.
- W2027423344 creator A5032789649 @default.
- W2027423344 creator A5037524730 @default.
- W2027423344 creator A5068325880 @default.
- W2027423344 creator A5070929438 @default.
- W2027423344 creator A5073923338 @default.
- W2027423344 creator A5082673762 @default.
- W2027423344 date "2013-07-01" @default.
- W2027423344 modified "2023-10-16" @default.
- W2027423344 title "Effects of medical therapies for acromegaly on glucose metabolism" @default.
- W2027423344 cites W1982685226 @default.
- W2027423344 cites W1983950740 @default.
- W2027423344 cites W1986096185 @default.
- W2027423344 cites W2004483751 @default.
- W2027423344 cites W2007799350 @default.
- W2027423344 cites W2023300718 @default.
- W2027423344 cites W2023961601 @default.
- W2027423344 cites W2045942594 @default.
- W2027423344 cites W2047894687 @default.
- W2027423344 cites W2060583741 @default.
- W2027423344 cites W2061913581 @default.
- W2027423344 cites W2075577428 @default.
- W2027423344 cites W2081387046 @default.
- W2027423344 cites W2084967524 @default.
- W2027423344 cites W2091101612 @default.
- W2027423344 cites W2092710971 @default.
- W2027423344 cites W2095591038 @default.
- W2027423344 cites W2098558143 @default.
- W2027423344 cites W2106911542 @default.
- W2027423344 cites W2107724413 @default.
- W2027423344 cites W2114972202 @default.
- W2027423344 cites W2118341413 @default.
- W2027423344 cites W2119044331 @default.
- W2027423344 cites W2123997600 @default.
- W2027423344 cites W2124620553 @default.
- W2027423344 cites W2131936635 @default.
- W2027423344 cites W2133795831 @default.
- W2027423344 cites W2147795491 @default.
- W2027423344 cites W2154079204 @default.
- W2027423344 cites W2158162115 @default.
- W2027423344 cites W2160234571 @default.
- W2027423344 cites W2166468225 @default.
- W2027423344 cites W2520432709 @default.
- W2027423344 cites W4211245154 @default.
- W2027423344 cites W4230284962 @default.
- W2027423344 cites W4233621632 @default.
- W2027423344 cites W4252914090 @default.
- W2027423344 doi "https://doi.org/10.1530/eje-13-0032" @default.
- W2027423344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23660641" @default.
- W2027423344 hasPublicationYear "2013" @default.
- W2027423344 type Work @default.
- W2027423344 sameAs 2027423344 @default.
- W2027423344 citedByCount "57" @default.
- W2027423344 countsByYear W20274233442014 @default.
- W2027423344 countsByYear W20274233442015 @default.
- W2027423344 countsByYear W20274233442016 @default.
- W2027423344 countsByYear W20274233442017 @default.
- W2027423344 countsByYear W20274233442018 @default.
- W2027423344 countsByYear W20274233442019 @default.
- W2027423344 countsByYear W20274233442020 @default.
- W2027423344 countsByYear W20274233442021 @default.
- W2027423344 countsByYear W20274233442022 @default.
- W2027423344 countsByYear W20274233442023 @default.
- W2027423344 crossrefType "journal-article" @default.
- W2027423344 hasAuthorship W2027423344A5000187560 @default.
- W2027423344 hasAuthorship W2027423344A5014452585 @default.
- W2027423344 hasAuthorship W2027423344A5016909731 @default.
- W2027423344 hasAuthorship W2027423344A5030686004 @default.
- W2027423344 hasAuthorship W2027423344A5032789649 @default.
- W2027423344 hasAuthorship W2027423344A5037524730 @default.
- W2027423344 hasAuthorship W2027423344A5068325880 @default.
- W2027423344 hasAuthorship W2027423344A5070929438 @default.
- W2027423344 hasAuthorship W2027423344A5073923338 @default.
- W2027423344 hasAuthorship W2027423344A5082673762 @default.
- W2027423344 hasBestOaLocation W20274233441 @default.
- W2027423344 hasConcept C10138342 @default.
- W2027423344 hasConcept C126322002 @default.
- W2027423344 hasConcept C134018914 @default.
- W2027423344 hasConcept C162324750 @default.
- W2027423344 hasConcept C17093226 @default.
- W2027423344 hasConcept C2776999253 @default.
- W2027423344 hasConcept C2777391703 @default.
- W2027423344 hasConcept C2777433750 @default.
- W2027423344 hasConcept C2778886798 @default.
- W2027423344 hasConcept C2779306644 @default.
- W2027423344 hasConcept C2780609358 @default.
- W2027423344 hasConcept C2780833929 @default.
- W2027423344 hasConcept C2984496839 @default.
- W2027423344 hasConcept C3018667095 @default.
- W2027423344 hasConcept C54400483 @default.
- W2027423344 hasConcept C555293320 @default.
- W2027423344 hasConcept C71315377 @default.
- W2027423344 hasConcept C71924100 @default.